Biotech · Public company · West Chester, PA, US
Verrica Pharmaceuticals Inc.
Ticker VRCA · SEC CIK 0001660334
Track this companyFree. Adds Verrica Pharmaceuticals Inc. to your Dealase workspace and tells you when its record changes.
Clinical trials104 recruiting or active
Pipeline programs14From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availableNo recent cash burn filed
Pipeline14
- CantharidinPhase 3 · Common Warts (Verruca Vulgaris)ClinicalTrials.gov · fetched Nov 12, 2026
- VehiclePhase 3 · Common WartsClinicalTrials.gov · fetched Nov 12, 2026
- Vehicle (US) / Vehicle (Japan)Phase 3 · Common WartsClinicalTrials.gov · fetched Nov 12, 2026
- VP-102Phase 3 · Common WartsClinicalTrials.gov · fetched Nov 12, 2026
- VP-102 - Cantharidin, Topical Film Forming SolutionPhase 3 · Molluscum ContagiosumClinicalTrials.gov · fetched Nov 12, 2026
- VP-102 (US) / TO-208 (Japan)Phase 3 · Common WartsClinicalTrials.gov · fetched Nov 12, 2026
- Part 1: VP-315 3 Day Dosing/WeekPhase 2 · Basal Cell CarcinomaClinicalTrials.gov · fetched Nov 12, 2026
- Part 2: VP-315 2 Day Dosing/Week - Split DosePhase 2 · Basal Cell CarcinomaClinicalTrials.gov · fetched Nov 12, 2026
- Part 2: VP-315 3 Day Dosing/Week - Loading DosePhase 2 · Basal Cell CarcinomaClinicalTrials.gov · fetched Nov 12, 2026
- Part 2: VP-315 3 Day Dosing/Week - No Loading DosePhase 2 · Basal Cell CarcinomaClinicalTrials.gov · fetched Nov 12, 2026
- Part 2: VP-315 3 Day Dosing/Week - Split DosePhase 2 · Basal Cell CarcinomaClinicalTrials.gov · fetched Nov 12, 2026
- VP-102 and applicatorPhase 2 · Condylomata AcuminataClinicalTrials.gov · fetched Nov 12, 2026
- VP-102 Cantharidin topical film forming solutionPhase 2 · Common WartClinicalTrials.gov · fetched Nov 12, 2026
- VP-102 with applicatorPhase 2 · Molluscum ContagiosumClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials10
- Safety and Systemic Exposure of YCANTH (VP-102) in Subjects With Common Warts (Verruca Vulgaris) (COVE-5)PHASE2 · NOT_YET_RECRUITING · started Oct 1, 2026ClinicalTrials.gov NCT07881952 · fetched Nov 12, 2026
- Cantharidin Application in Patients With Common Warts (Verruca Vulgaris) (COVE-3)PHASE3 · RECRUITING · started Jun 15, 2026ClinicalTrials.gov NCT07637734 · fetched Nov 12, 2026
- Long-Term Follow-up Study of Cantharidin (YCANTH [VP-102/TO-208]) in Patients With Common Warts (Verruca Vulgaris)PHASE3 · RECRUITING · started Mar 11, 2026ClinicalTrials.gov NCT07457918 · fetched Nov 12, 2026
- Cantharidin Application in Patients With Common Warts (Verruca Vulgaris) (COVE-2)PHASE3 · ACTIVE_NOT_RECRUITING · started Dec 17, 2025ClinicalTrials.gov NCT07246590 · fetched Nov 12, 2026
- Open-Label Proof of Concept Study of VP-315 in Basal Cell CarcinomaPHASE2 · COMPLETED · started Feb 1, 2022ClinicalTrials.gov NCT05188729 · fetched Nov 12, 2026
- A Placebo-Controlled Study Using VP-102 in the Treatment of External Genital WartsPHASE2 · COMPLETED · started Jun 25, 2019ClinicalTrials.gov NCT03981822 · fetched Nov 12, 2026
- Cantharidin and Occlusion in Verruca EpitheliumPHASE2 · COMPLETED · started Mar 27, 2018ClinicalTrials.gov NCT03487549 · fetched Nov 12, 2026
- Cantharidin Application in Molluscum Patients-1PHASE3 · COMPLETED · started Mar 21, 2018ClinicalTrials.gov NCT03377790 · fetched Nov 12, 2026
- Cantharidin Application in Molluscum PatientsPHASE3 · COMPLETED · started Feb 14, 2018ClinicalTrials.gov NCT03377803 · fetched Nov 12, 2026
- Evaluation of Systemic Exposure to VP-102 in Subjects With Molluscum Contagiosum.PHASE2 · COMPLETED · started Jun 8, 2017ClinicalTrials.gov NCT03186378 · fetched Nov 12, 2026
SEC filings12
- 10-Q · 10-QSEC EDGAR · filed Aug 6, 2026 · fetched Nov 12, 2026
- 8-K · 8-KSEC EDGAR · filed Aug 6, 2026 · fetched Nov 12, 2026
- 8-K · 8-KSEC EDGAR · filed Jun 9, 2026 · fetched Nov 12, 2026
- 10-Q · 10-QSEC EDGAR · filed May 12, 2026 · fetched Nov 12, 2026
- 8-K · 8-KSEC EDGAR · filed May 12, 2026 · fetched Nov 12, 2026
- 10-K · 10-KSEC EDGAR · filed Mar 11, 2026 · fetched Nov 12, 2026
- 8-K · 8-KSEC EDGAR · filed Mar 11, 2026 · fetched Nov 12, 2026
- 8-K · 8-KSEC EDGAR · filed Dec 30, 2025 · fetched Nov 12, 2026
- 8-K · 8-KSEC EDGAR · filed Nov 24, 2025 · fetched Nov 12, 2026
- 10-Q · 10-QSEC EDGAR · filed Nov 14, 2025 · fetched Nov 12, 2026
- 8-K · 8-KSEC EDGAR · filed Nov 14, 2025 · fetched Nov 12, 2026
- 10-Q · 10-QSEC EDGAR · filed Aug 12, 2025 · fetched Nov 12, 2026